Evidence-led education
PLUSGBUK / MEDICINES / ALPRAZOLAM 20 Sep 2026

Medicines · Evidence guide

Alprazolam (Xanax): Effects, Dependence, Withdrawal and UK Law

Written by Daniel Mercer
Updated 20 September 2026
Reading time 4 min
Clinical review Jennifer Jan, MD
Alprazolam (Xanax): Effects, Dependence, Withdrawal and UK Law

“Xanax” is one of the most recognisable benzodiazepine brand names online, but that familiarity creates a problem in the UK market: a tablet sold as Xanax is not automatically a genuine alprazolam medicine.

Alprazolam is a benzodiazepine. Like other medicines in the group, it can reduce anxiety and produce sedation, but it can also impair memory and coordination, interact dangerously with other depressants, and cause physical dependence.

The second issue is the supply route. Tablets obtained outside a regulated pharmacy can be mislabelled or counterfeit, so appearance and imprint are not enough to establish identity.

How alprazolam works

Alprazolam enhances GABA-related inhibition in the central nervous system. This can reduce anxiety and produce a calming effect, but the same mechanism can also cause drowsiness, slowed reactions and impaired coordination.

Compared with diazepam, alprazolam has a shorter persistence in the body. That difference matters particularly when dependence has developed because withdrawal symptoms can emerge more quickly after a dose is missed or stopped.

Why dependence deserves more attention than the brand name

People sometimes judge benzodiazepine risk by whether a tablet was prescribed or obtained elsewhere. Physical dependence does not follow that distinction.

The MHRA states that benzodiazepine dependence can occur at therapeutic doses and may become established within weeks. In 2026, the regulator strengthened warnings across benzodiazepines and z-drugs to make addiction, dependence, tolerance and withdrawal risks more explicit.

Increasing the dose without medical advice because the original amount “does not work like it used to” may indicate tolerance rather than worsening anxiety alone.

Withdrawal can be serious

Stopping alprazolam abruptly after regular use can produce rebound anxiety, insomnia, tremor, sweating, agitation and perceptual disturbances. Severe benzodiazepine withdrawal can include seizures, delirium or psychosis.

The MHRA’s professional guidance specifically identifies alprazolam as a benzodiazepine where withdrawal management may involve conversion to a longer-acting medicine such as diazepam in appropriate clinical circumstances.

That is a medical decision, not a do-it-yourself conversion formula. Dose equivalence varies between individuals, and other conditions or medicines may change the plan.

See our guide to alprazolam and Xanax withdrawal.

Alcohol, opioids and other sedatives

The most important interaction principle is straightforward: combining sedatives can deepen central nervous system depression.

Alcohol can increase drowsiness, memory impairment and poor coordination. Opioids introduce a more serious concern because combined respiratory depression can become life-threatening.

A person may appear merely asleep when their level of consciousness is dangerously reduced.

Call 999 if someone cannot be woken normally or has slow, difficult or abnormal breathing.

Counterfeit “Xanax” changes the risk

A tablet carrying a bar shape, colour or imprint associated with Xanax does not prove it contains alprazolam. Counterfeit medicines can copy markings convincingly.

The problem is not purely legal. If the active drug is different from what the person expects, interaction and overdose risk become harder to judge.

Our guide to counterfeit Xanax in the UK explains why packaging and appearance cannot authenticate an unregulated tablet.

Alprazolam and anxiety treatment

Benzodiazepines can rapidly reduce anxiety symptoms, but rapid relief is not the same as being the preferred long-term treatment.

NICE advises that benzodiazepines should not be routinely offered for generalised anxiety disorder except as a short-term measure during crises. Long-term management may involve psychological treatment or other medicines depending on the diagnosis and individual circumstances.

This matters because repeated short-term relief can reinforce reliance on a benzodiazepine while tolerance and withdrawal begin to complicate the original anxiety.

UK controlled-drug status

Alprazolam is controlled under UK misuse-of-drugs legislation as a Class C benzodiazepine. The Home Office’s controlled-drug material includes alprazolam among Class C benzodiazepines.

Unauthorised possession of a Class C controlled drug can carry a maximum penalty of two years in prison, an unlimited fine, or both. Supply and production can carry up to 14 years, an unlimited fine, or both.

See alprazolam and Xanax law in the UK for the legal position in more detail.

Buying medicine online

The safe question is not whether an online tablet “looks genuine”. It is whether the medicine is being supplied through a lawful, regulated route after an appropriate clinical assessment.

Websites that promise controlled prescription medicines without meaningful prescribing safeguards should be treated with caution.

See our guide to alprazolam and online medicine safety in the UK.

When to get medical advice

Someone taking alprazolam regularly who wants to stop should speak with a healthcare professional rather than abruptly discontinuing it. Anyone experiencing severe withdrawal symptoms, seizures, hallucinations or profound confusion needs urgent medical attention.

For suspected overdose or combined use with opioids, alcohol or other sedatives, reduced consciousness or breathing difficulty is an emergency.

References

Written by

Daniel Mercer

Daniel Mercer is a health and drug policy writer covering ketamine, harm reduction, controlled substances and emerging mental health treatments. He translates clinical research, UK public-health guidance and drug policy into clear information for non-specialist readers, with particular attention to the differences between medically supervised treatment and substances obtained through unregulated channels.

Jennifer Jan MD
Clinically reviewed by

Jennifer Jan, MD